Literature DB >> 26683804

Surgically Treated Pediatric Nonpapillary Thyroid Carcinoma.

Samuel Golpanian1, Jun Tashiro1, Juan E Sola1, Casey Allen1, John I Lew1, Anthony R Hogan1, Holly L Neville1, Eduardo A Perez1.   

Abstract

Introduction This study aims to update outcomes and predictors of survival on pediatric thyroid carcinoma, specifically examining pediatric patients with nonpapillary thyroid carcinoma who underwent surgical resection. Methods Surveillance, epidemiology, and end results database were searched for pediatric cases (< 20 years old) of surgically treated nonpapillary thyroid carcinoma diagnosed from 1973 to 2011. Demographics, clinical characteristics, and survival outcomes were analyzed using standard statistical methods. All follicular, medullary, Hürthle-cell, and nonencapsulated sclerosing carcinoma types were included. Results A total of 493 cases were identified. The overall incidence was 0.096/100,000 persons per year. The mean age at diagnosis was 15 years and highest incidence was found in whites, females, and patients aged 15 to 19 years. Most patients had localized (60%) or regional disease (35%) and only 38% received radiation (any type). Subtotal/total thyroidectomy was the most common procedure performed (83%) and 47% had lymph node sampling. The most common histologies were follicular (54%) and medullary (28%). Most tumors were > 2cm in size (63%). Overall 30-year survival was 91% but higher for females (94%, p = 0.02) and for local disease (92%). Disease-specific survival was highest for those with no lymph node sampling and negative lymph nodes. On multivariate analysis for medullary type only stage was an independent prognostic indicator of survival. Gender, age, tumor size, histology, and disease extent were not associated with an increased risk of mortality. Conclusions Incidence of pediatric nonpapillary thyroid cancer is low. Females have a higher incidence but similar survival to males. Stage is the only independent prognostic indicator of survival for patients with medullary thyroid cancer. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 26683804     DOI: 10.1055/s-0035-1569150

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  2 in total

1.  Lymph node metastases in pediatric medullary thyroid carcinoma.

Authors:  Jamie R Oliver; Kepal N Patel; Clifford M Chang; Chelsey K Baldwin; Preneet C Brar; Luc G T Morris; Babak Givi
Journal:  Surgery       Date:  2021-04-08       Impact factor: 4.348

2.  Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span.

Authors:  Chantal A Lebbink; Medard F M van den Broek; Annemiek B G Kwast; Joep P M Derikx; Miranda P Dierselhuis; Schelto Kruijff; Thera P Links; A S Paul van Trotsenburg; Gerlof D Valk; Menno R Vriens; Annemarie A Verrijn Stuart; Hanneke M van Santen; Henrike E Karim-Kos
Journal:  Cancers (Basel)       Date:  2021-10-12       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.